Dexcom | Passività Correnti





Passività Correnti Cambiamento Data
Abbott USD 16.5B 1.91B 2025-12
Align Technology USD 1.92B 46.45M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Avanos Medical USD 147.9M 13.3M 2025-09
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.11B 102.7M 2025-09
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Globus Medical USD 465.96M 41.29M 2025-09
Hologic USD 951.3M 25.9M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 364.05M 565.75M 2025-09
J&J USD 54.13B 3.26B 2025-12
Masimo USD 369.7M 222.4M 2025-09
Medtronic USD 9.94B 1.6B 2025-09
Merit Medical Systems USD 230.48M 4.9M 2025-09
Roche Holding CHF 28B 421M 2025-12
Solventum Corp USD 2.94B 318M 2025-09
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 773.03M 56.88M 2025-09
West Pharmaceutical Services USD 654.9M 19.5M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12


Dexcom Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.